Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Mallinckrodt
McKinsey
McKesson
Colorcon

Last Updated: December 11, 2019

DrugPatentWatch Database Preview

Litigation Details for TYCO HEALTHCARE GROUP LP v. PHARMACEUTICAL HOLDINGS CORPORATION (D.N.J. 2007)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

TYCO HEALTHCARE GROUP LP v. PHARMACEUTICAL HOLDINGS CORPORATION (D.N.J. 2007)

Docket   Start Trial Date Filed 2007-03-20
Court District Court, D. New Jersey Date Terminated 2013-04-30
Cause 35:271 Patent Infringement Assigned To Stanley R. Chesler
Jury Demand Defendant Referred To Magistrate Judge Cathy L. Wald
Parties MALLINCKRODT INC.; MUTUAL PHARMACEUTICAL COMPANY, INC.; PHARMACEUTICAL HOLDINGS CORPORATION; TYCO HEALTHCARE GROUP LP; UNITED RESEARCH LABORATORIES, INC.
Patents 5,030,632; 5,211,954; 5,326,758
Attorneys CARACO PHARCEUTICAL LABORATORIES; CARISSA L. RODRIGUE; ERICA SUSAN HELMS; JAMES S. RICHTER; JEFFREY P. CATENACCI; JOHN EDMUND FLAHERTY; JONATHAN M.H. SHORT; KAREN A. CONFOY; MARK H. ANANIA; SYMONE J. REDWINE; WILLIAM J. HELLER
Link to Docket External link to docket
Small Molecule Drugs cited in TYCO HEALTHCARE GROUP LP v. PHARMACEUTICAL HOLDINGS CORPORATION
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for TYCO HEALTHCARE GROUP LP v. PHARMACEUTICAL HOLDINGS CORPORATION (D.N.J. 2007)

Date Filed Document No. Description Snippet Link To Document
2009-01-05 193 construction of claim terms in U.S. Patent No. 5,211,954 (the “’954 patent”). This Court has examined the…an action for patent infringement. Briefly, Mallinkrodt owns U.S. Patent No. 5,211,954, which is directed…of four patents, but three of those patents have since expired, leaving only the ’954 patent at issue… It is a bedrock principle of patent law that the claims of a patent define the invention to…construction A court’s determination “of patent infringement requires a two-step process: first External link to document
2009-01-05 194 regarding the claim construction terms in U.S. Patent No. 5,211,954. Signed by Judge Stanley R. Chesler on 01… 30 April 2013 2:07-cv-01299-SRC-CLW Patent Defendant District Court, D. External link to document
2009-08-04 294 action for patent infringement. Briefly, Mallinkrodt Inc. owns U.S. Patent No. 5,211,954 (the “’954…undisputed facts: 1. Tyco owns U.S. Patent No. 5,211,954. 2. On November 1, 2006, Mutual…claim of infringement of claim 2 of U.S. Patent No. 5,211,954, pursuant to 35 U.S.C. § …claim of infringement of claim 2 of U.S. Patent No. 5,211,954, pursuant to 35 U.S.C. § …of four patents, but three of those patents have since expired, leaving only the ’954 patent at issue External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Baxter
Dow
Johnson and Johnson
Harvard Business School
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.